241 related articles for article (PubMed ID: 28473136)
21. Relationship Between Optimism and Outcomes in Patients With Chronic Angina Pectoris.
Fanaroff AC; Prather K; Brucker A; Wojdyla D; Davidson-Ray L; Mark DB; Williams RB; Barefoot J; Weisz G; Ben-Yehuda O; Stone GW; Ohman EM; Alexander KP
Am J Cardiol; 2019 May; 123(9):1399-1405. PubMed ID: 30771861
[TBL] [Abstract][Full Text] [Related]
22. Antihyperglycemic and Metabolic Effects of Ranolazine in Patients With Diabetes Mellitus.
Gilbert BW; Sherard M; Little L; Branstetter J; Meister A; Huffman J
Am J Cardiol; 2018 Feb; 121(4):509-512. PubMed ID: 29274809
[TBL] [Abstract][Full Text] [Related]
23. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
[TBL] [Abstract][Full Text] [Related]
24. Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry).
Storey KM; Wang J; Garberich RF; Bennett NM; Traverse JH; Arndt TL; Schmidt CW; Henry TD
Am J Cardiol; 2020 Aug; 129():1-4. PubMed ID: 32540170
[TBL] [Abstract][Full Text] [Related]
25. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
[TBL] [Abstract][Full Text] [Related]
26. Effects of ranolazine on various outcomes in patients with stable angina: an updated meta-analysis.
Manolis A; Kallistratos M; Poulimenos L; Zamfir T; Thomopoulos C
Hellenic J Cardiol; 2023; 71():26-32. PubMed ID: 36481415
[TBL] [Abstract][Full Text] [Related]
27. Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis: The MARINA Randomized, Double-Blinded, Controlled Pilot Trial.
Koh JS; Hung OY; Eshtehardi P; Kumar A; Rabah R; Raad M; Kumar S; Chaudhry S; Gupta S; Hosseini H; Brilakis E; Corban M; Sabbak N; Burnett GM; Liu C; Mehta PK; Quyyumi AA; Samady H
Circ Cardiovasc Interv; 2020 Dec; 13(12):e008204. PubMed ID: 33272036
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
Wilson SR; Scirica BM; Braunwald E; Murphy SA; Karwatowska-Prokopczuk E; Buros JL; Chaitman BR; Morrow DA
J Am Coll Cardiol; 2009 Apr; 53(17):1510-6. PubMed ID: 19389561
[TBL] [Abstract][Full Text] [Related]
29. Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life.
Nguyen E; Coleman CI; Kohn CG; Weeda ER
Int J Cardiol; 2018 Dec; 273():34-38. PubMed ID: 30266352
[TBL] [Abstract][Full Text] [Related]
30. Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial.
Abdallah MS; Wang K; Magnuson EA; Spertus JA; Farkouh ME; Fuster V; Cohen DJ;
JAMA; 2013 Oct; 310(15):1581-90. PubMed ID: 24129463
[TBL] [Abstract][Full Text] [Related]
31. Ranolazine for stable angina pectoris.
Salazar CA; Basilio Flores JE; Veramendi Espinoza LE; Mejia Dolores JW; Rey Rodriguez DE; Loza Munárriz C
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD011747. PubMed ID: 28178363
[TBL] [Abstract][Full Text] [Related]
32. Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes.
Eckel RH; Henry RR; Yue P; Dhalla A; Wong P; Jochelson P; Belardinelli L; Skyler JS
Diabetes Care; 2015 Jul; 38(7):1189-96. PubMed ID: 26049552
[TBL] [Abstract][Full Text] [Related]
33. Anti-anginal medication titration among patients with residual angina 6-months after chronic total occlusion percutaneous coronary intervention: insights from OPEN CTO registry.
Sheehy JP; Qintar M; Arnold SV; Hirai T; Sapontis J; Jones PG; Tang Y; Lombardi W; Karmpaliotis D; Moses JW; Patterson C; Cohen DJ; Amin AP; Nicholson WJ; Spertus JA; Grantham JA; Salisbury AC
Eur Heart J Qual Care Clin Outcomes; 2019 Oct; 5(4):370-379. PubMed ID: 30895291
[TBL] [Abstract][Full Text] [Related]
34. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
[TBL] [Abstract][Full Text] [Related]
35. Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial.
Arnold SV; McGuire DK; Spertus JA; Tang F; Yue P; Inzucchi SE; Belardinelli L; Chaitman BR; Kosiborod M
Am Heart J; 2015 Oct; 170(4):753-759.e2. PubMed ID: 26386799
[TBL] [Abstract][Full Text] [Related]
36. A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics.
Ferrari R; Ford I; Fox K; Marzilli M; Tendera M; Widimský P; Challeton JP; Danchin N
Am Heart J; 2019 Apr; 210():98-107. PubMed ID: 30771737
[TBL] [Abstract][Full Text] [Related]
37. Ranolazine: a review of its use in chronic stable angina pectoris.
Siddiqui MA; Keam SJ
Drugs; 2006; 66(5):693-710. PubMed ID: 16620147
[TBL] [Abstract][Full Text] [Related]
38. A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.
Pelliccia F; Pasceri V; Marazzi G; Rosano G; Greco C; Gaudio C
Am Heart J; 2012 Jun; 163(6):1019-23. PubMed ID: 22709755
[TBL] [Abstract][Full Text] [Related]
39. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Murphy SA; Budaj A; Varshavsky S; Wolff AA; Skene A; McCabe CH; Braunwald E;
JAMA; 2007 Apr; 297(16):1775-83. PubMed ID: 17456819
[TBL] [Abstract][Full Text] [Related]
40. Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials.
Wenger NK; Chaitman B; Vetrovec GW
Am J Cardiol; 2007 Jan; 99(1):11-8. PubMed ID: 17196454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
